Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 296

1.

Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.

Messing EM, Tangen CM, Lerner SP, Sahasrabudhe DM, Koppie TM, Wood DP Jr, Mack PC, Svatek RS, Evans CP, Hafez KS, Culkin DJ, Brand TC, Karsh LI, Holzbeierlein JM, Wilson SS, Wu G, Plets M, Vogelzang NJ, Thompson IM Jr.

JAMA. 2018 May 8;319(18):1880-1888. doi: 10.1001/jama.2018.4657.

PMID:
29801011
2.

Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921.

Hussain M, Tangen CM, Thompson IM Jr, Swanson GP, Wood DP, Sakr W, Dawson NA, Haas NB, Flaig TW, Dorff TB, Lin DW, Crawford ED, Quinn DI, Vogelzang NJ, Glode LM.

J Clin Oncol. 2018 May 20;36(15):1498-1504. doi: 10.1200/JCO.2017.76.4126. Epub 2018 Apr 6.

3.

Functional Outcomes Following Nerve Sparing Prostatectomy Augmented with Seminal Vesicle Sparing Compared to Standard Nerve Sparing Prostatectomy: Results from a Randomized Controlled Trial.

Gilbert SM, Dunn RL, Miller DC, Montgomery JS, Skolarus TA, Weizer AZ, Wood DP Jr, Hollenbeck BK.

J Urol. 2017 Sep;198(3):600-607. doi: 10.1016/j.juro.2017.03.133. Epub 2017 Apr 7.

PMID:
28392393
4.

Impact characteristics of a vehicle population in low speed front to rear collisions.

Nishimura N, Simms CK, Wood DP.

Accid Anal Prev. 2015 Jun;79:1-12. doi: 10.1016/j.aap.2015.02.001. Epub 2015 Mar 18.

PMID:
25795922
5.

Re: Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy.

Wood DP.

J Urol. 2015 Jan;193(1):73. doi: 10.1016/j.juro.2014.10.020. Epub 2014 Oct 13. No abstract available.

PMID:
25523654
6.

Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco FJ Jr, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ.

Eur Urol. 2015 Jun;67(6):1160-1167. doi: 10.1016/j.eururo.2014.09.019. Epub 2014 Oct 6.

8.

Prostate capsule sparing versus nerve sparing radical cystectomy for bladder cancer: results of a randomized, controlled trial.

Jacobs BL, Daignault S, Lee CT, Hafez KS, Montgomery JS, Montie JE, Humrich JE, Hollenbeck BK, Wood DP Jr, Weizer AZ.

J Urol. 2015 Jan;193(1):64-70. doi: 10.1016/j.juro.2014.07.090. Epub 2014 Jul 24.

9.

Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer.

Kozminski MA, Palapattu GS, Mehra R, Montgomery JS, Weizer AZ, Skolarus TA, Hollenbeck BK, Miller DC, He C, Tomlins S, Montie JE, Feng FY, Wood DP, Kunju LP, Morgan TM.

Urology. 2014 Aug;84(2):373-8. doi: 10.1016/j.urology.2014.03.037. Epub 2014 Jun 21.

PMID:
24958484
10.

Virtual reality graded exposure therapy with arousal control for the treatment of combat related posttraumatic stress disorder: a follow up case series.

Wood DP, Mclay RL, Webb-Murphy J, Wiederhold MD, Spira JL, Pyne JM, Wiederhold BK.

Stud Health Technol Inform. 2014;199:141-5.

PMID:
24875708
11.

Re: recurrence of high-risk bladder cancer: a population-based analysis.

Wood DP.

J Urol. 2014 May;191(5):1264. doi: 10.1016/j.juro.2014.02.083. Epub 2014 Feb 22. No abstract available.

PMID:
24745483
12.

Effect of virtual reality PTSD treatment on mood and neurocognitive outcomes.

McLay R, Ram V, Murphy J, Spira J, Wood DP, Wiederhold MD, Wiederhold BK, Johnston S, Reeves D.

Cyberpsychol Behav Soc Netw. 2014 Jul;17(7):439-46. doi: 10.1089/cyber.2013.0383. Epub 2014 Mar 17.

PMID:
24635120
13.

Re: diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer.

Wood DP.

J Urol. 2014 Feb;191(2):556. doi: 10.1016/j.juro.2013.10.136. Epub 2013 Oct 29. No abstract available.

PMID:
24411908
14.

Re: role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studies.

Wood DP.

J Urol. 2014 Feb;191(2):348. doi: 10.1016/j.juro.2013.10.134. Epub 2013 Oct 30. No abstract available.

PMID:
24411847
17.

Open surgical partial nephrectomy for upper tract urothelial carcinoma.

Macari D, Faerber GJ, Hafez KS, Hollenbeck BK, Montie JE, Wood DP, Wolf JS Jr.

Int J Urol. 2014 Apr;21(4):409-12. doi: 10.1111/iju.12301. Epub 2013 Oct 17.

18.

Re: Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program.

Wood DP.

J Urol. 2013 Nov;190(5):1714. doi: 10.1016/j.juro.2013.07.038. Epub 2013 Jul 26. No abstract available.

PMID:
24120776
19.

Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality.

Stephenson AJ, Eggener SE, Hernandez AV, Klein EA, Kattan MW, Wood DP Jr, Rabah DM, Eastham JA, Scardino PT.

Eur Urol. 2014 Apr;65(4):675-80. doi: 10.1016/j.eururo.2013.08.036. Epub 2013 Aug 27.

PMID:
24035631
20.

Re: Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy.

Wood DP.

J Urol. 2013 Oct;190(4):1206. doi: 10.1016/j.juro.2013.06.047. Epub 2013 Jun 21. No abstract available.

PMID:
24029307
21.

A one-day couple group intervention to enhance sexual recovery for surgically treated men with prostate cancer and their partners: a pilot study.

Wittmann D, He C, Mitchell S, Wood DP Jr, Hola V, Thelen-Perry S, Montie JE.

Urol Nurs. 2013 May-Jun;33(3):140-7.

PMID:
23930447
22.

Re: Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin.

Wood DP.

J Urol. 2013 Jun;189(6):2091. doi: 10.1016/j.juro.2013.02.088. Epub 2013 Feb 26. No abstract available.

PMID:
23663596
23.

Early postoperative urinary and sexual function predicts functional recovery 1 year after prostatectomy.

Ellison JS, He C, Wood DP.

J Urol. 2013 Oct;190(4):1233-8. doi: 10.1016/j.juro.2013.04.045. Epub 2013 Apr 19.

PMID:
23608677
24.

Re: sunitinib malate provides activity against murine bladder tumor growth and invasion in a preclinical orthotopic model.

Wood DP.

J Urol. 2013 May;189(5):1991-2. doi: 10.1016/j.juro.2013.03.002. Epub 2013 Mar 5. No abstract available.

PMID:
23594673
25.

Re: survival after treatment for carcinoma invading bladder muscle: a dutch population-based study on the impact of hospital volume.

Wood DP, Penson DP.

J Urol. 2013 May;189(5):1695-6. doi: 10.1016/j.juro.2013.03.003. Epub 2013 Mar 5. No abstract available.

PMID:
23594625
26.

Re: loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.

Wood DP.

J Urol. 2013 Apr;189(4):1597. doi: 10.1016/j.juro.2012.12.067. Epub 2012 Dec 28. No abstract available.

PMID:
23561391
27.

Re: increased incidence of penile cancer and high-grade penile intraepithelial neoplasia in denmark 1978-2008: a nationwide population-based study.

Wood DP.

J Urol. 2013 Apr;189(4):1325. doi: 10.1016/j.juro.2012.12.066. Epub 2012 Dec 28. No abstract available.

PMID:
23561347
28.

Re: metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer.

Wood DP.

J Urol. 2013 Apr;189(4):1288. doi: 10.1016/j.juro.2012.12.111. Epub 2013 Jan 7. No abstract available.

PMID:
23561341
29.

Re: a phase 2 cancer chemoprevention biomarker trial of isoflavone g-2535 (genistein) in presurgical bladder cancer patients.

Wood DP.

J Urol. 2013 Apr;189(4):1287-8. doi: 10.1016/j.juro.2013.01.006. Epub 2013 Jan 4. No abstract available.

PMID:
23561340
30.

Re: interobserver variability limits exact preoperative staging by computed tomography in bladder cancer.

Wood DP.

J Urol. 2013 Mar;189(3):843-4. doi: 10.1016/j.juro.2012.11.104. Epub 2013 Jan 22. No abstract available.

PMID:
23394635
31.

Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy.

DeLancey JO, Wood DP Jr, He C, Montgomery JS, Weizer AZ, Miller DC, Jacobs BL, Montie JE, Hollenbeck BK, Skolarus TA.

Urology. 2013 Feb;81(2):354-7. doi: 10.1016/j.urology.2012.09.034.

PMID:
23374801
32.

Re: discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy.

Wood DP.

J Urol. 2013 Feb;189(2):485. doi: 10.1016/j.juro.2012.10.105. Epub 2012 Dec 20. No abstract available.

PMID:
23312155
33.

Re: extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer.

Wood DP.

J Urol. 2013 Feb;189(2):484. doi: 10.1016/j.juro.2012.10.104. Epub 2012 Dec 20. No abstract available.

PMID:
23312154
35.

Re: Quality of care in patients with bladder cancer: a case report?

Wood DP.

J Urol. 2013 Jan;189(1):73-4. doi: 10.1016/j.juro.2012.09.113. Epub 2012 Nov 16. No abstract available.

PMID:
23235211
36.
37.

Re: Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens.

Wood DP.

J Urol. 2013 Jan;189(1):72-3. doi: 10.1016/j.juro.2012.09.112. Epub 2012 Nov 16. No abstract available.

PMID:
23235209
38.

Re: Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, osaka medical college regimen.

Wood DP.

J Urol. 2012 Dec;188(6):2150-1. doi: 10.1016/j.juro.2012.08.080. Epub 2012 Oct 18. No abstract available.

PMID:
23141222
39.

Stratification of postprostatectomy urinary function using expanded prostate cancer index composite.

Ellison JS, He C, Wood DP.

Urology. 2013 Jan;81(1):56-60. doi: 10.1016/j.urology.2012.09.016. Epub 2012 Nov 2.

PMID:
23122544
40.

Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden.

Young A, Palanisamy N, Siddiqui J, Wood DP, Wei JT, Chinnaiyan AM, Kunju LP, Tomlins SA.

Am J Clin Pathol. 2012 Nov;138(5):685-96. doi: 10.1309/AJCPU7PPWUPYG8OH.

41.

Re: Maximizing intravesical therapy options: is there an advantage to the administration of perioperative mitomycin C prior to an induction course of BCG?

Wood DP.

J Urol. 2012 Nov;188(5):1724-5. doi: 10.1016/j.juro.2012.07.113. Epub 2012 Sep 19. No abstract available.

PMID:
23059213
43.

Re: Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.

Wood DP.

J Urol. 2012 Jun;187(6):2024. doi: 10.1016/j.juro.2012.02.2550. Epub 2012 Apr 11. No abstract available.

PMID:
22579172
44.

Understanding criteria for surveillance of patients with a small renal mass.

Jacobs BL, Tan HJ, Montgomery JS, Weizer AZ, Wood DP, Miller DC, Wolf JS Jr, Hafez KS.

Urology. 2012 May;79(5):1027-32. doi: 10.1016/j.urology.2011.12.052.

45.

Matched comparison of robotic-assisted and open radical cystectomy.

Styn NR, Montgomery JS, Wood DP, Hafez KS, Lee CT, Tallman C, He C, Crossley H, Hollenbeck BK, Weizer AZ.

Urology. 2012 Jun;79(6):1303-8. doi: 10.1016/j.urology.2012.01.055. Epub 2012 Apr 17.

PMID:
22516354
46.

Re: urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.

Wood DP, Babayan RK.

J Urol. 2012 May;187(5):1587-8. doi: 10.1016/j.juro.2012.01.116. Epub 2012 Mar 28. No abstract available.

PMID:
22494716
47.

Re: the role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.

Wood DP.

J Urol. 2012 May;187(5):1586-7. doi: 10.1016/j.juro.2012.01.115. Epub 2012 Mar 28. No abstract available.

PMID:
22494715
48.

Re: Instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: an animal model.

Wood DP.

J Urol. 2012 Apr;187(4):1508. doi: 10.1016/j.juro.2012.01.006. Epub 2012 Feb 17. No abstract available.

PMID:
22423953
49.

Re: Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model.

Wood DP.

J Urol. 2012 Apr;187(4):1507-8. doi: 10.1016/j.juro.2012.01.005. Epub 2012 Feb 17. No abstract available.

PMID:
22423951
50.

Re: bacillus Calmette-Guérin osteomyelitis mimicking spinal metastasis from urothelial cell carcinoma of the bladder.

Wood DP.

J Urol. 2012 Mar;187(3):881. doi: 10.1016/j.juro.2011.11.076. Epub 2012 Jan 18. No abstract available.

PMID:
22325501

Supplemental Content

Support Center